Vifor Pharma AG reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CHF 1,754.2 million compared to CHF 1,705.6 million a year ago. Net income was CHF 144.4 million compared to CHF 359.6 million a year ago.

Basic earnings per share from continuing operations was CHF 2.26 compared to CHF 2.14 a year ago. Diluted earnings per share from continuing operations was CHF 2.25 compared to CHF 2.13 a year ago. Basic earnings per share was CHF 2.23 compared to CHF 5.54 a year ago.

Diluted earnings per share was CHF 2.22 compared to CHF 5.53 a year ago.